Tower Research Capital LLC (Trc) Olema Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 22,714 shares of OLMA stock, worth $112,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,714
Previous 1,478
1436.81%
Holding current value
$112,888
Previous $17,000
676.47%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding OLMA
# of Institutions
160Shares Held
69.2MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$37.1 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$36.3 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$28.4 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$18.2 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $201M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...